Joshua S. Prince serves as Executive at Vistagen Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joshua S. Prince has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2025 involved receiving (via award) 4,386 shares valued at $2.5K.
Joshua S. Prince currently holds 15,249 shares of Vistagen Therapeutics, Inc. (VTGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua S. Prince has been a net neutral trader of VTGN stock. They have purchased $0 and sold $0 worth of shares.
Joshua S. Prince's most recent insider trade was on Dec 31, 2025, when they sold 4,386 shares at $0.56 per share.
Get notified when new Form 4 filings are submitted
| $1.70 |
| Discretionary |
| Jun 28, 2024 | VTGN | $7.9K | Award | 2,671 | $2.96 | Discretionary |